 NAPLES, Fla., May 24, 2021 PRNewswire -- Enveric Biosciences NASDAQ: ENVB Enveric or the Company, a patient-first biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer patients, today announced that it has entered into a definitive agreement to acquire MagicMed Industries Inc. 